Literature DB >> 34007998

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.

Francesco Paolo Bianchi1, Cinzia Annatea Germinario1, Giovanni Migliore2, Luigi Vimercati3, Andrea Martinelli1, Annamaria Lobifaro1, Silvio Tafuri1, Pasquale Stefanizzi1.   

Abstract

In the preregistration trial, data on efficacy of BNT162b2 mRNA vaccine against SARS-CoV-2 infection were not collected. This study aimed to evaluate vaccine effectiveness (VE) against documented infection. Bari Policlinico University Hospital health care workers (HCWs) who completed the vaccination schedule were matched with HCWs who had refused vaccination. VE for documented infection was 61.9% (95% confidence interval [CI], 19.2%-82.0%) 14-20 days after first dose, 87.9% (95% CI, 51.7%-97.0%) 21-27 days after first dose, and 96.0% (95% CI, 82.2%-99.1%) 7 or more days after second dose. Unvaccinated HCWs remain a concern in the context of the pandemic emergency.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; documented infection; healthcare workers; vaccine effectiveness

Year:  2021        PMID： 34007998      PMCID： PMC8194590          DOI： 10.1093/infdis/jiab262

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Immunosuppressed non-responders to two doses of mRNA SARS-CoV-2 vaccines achieve an immune response comparable to those of immunocompetent individuals after a third dose.

Authors:  Andrew N Margioris
Journal:  Hormones (Athens)       Date:  2022-06-24       Impact factor: 3.419

2.  The Effectiveness of COVID-19 Vaccines in Preventing Hospitalizations During the Delta Wave: A Patient-Population Study at a Major Referral Center.

Authors:  Ahmad Salman; Ghaidaa Elsaddik; Zeinab El Mawla; Rim Masri; Matina Hamadeh; Amena Khatoon; Michelle W Saliba; Afaf Michel Minari; Mahmoud Hassoun; Pierre Abi Hanna
Journal:  Cureus       Date:  2022-06-17

3.  Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination.

Authors:  Giuseppina Sanna; Alessandra Marongiu; Davide Firinu; Cristina Piras; Gianluigi Franci; Massimiliano Galdiero; Giuseppe Pala; Vanessa Palmas; Fabrizio Angius; Roberto Littera; Andrea Perra; Germano Orrù; Marcello Campagna; Giulia Costanzo; Federico Meloni; Ferdinando Coghe; Luchino Chessa; Aldo Manzin
Journal:  Vaccines (Basel)       Date:  2022-03-29

4.  Comparison of Three Different Waves in Healthcare Workers during the COVID-19 Pandemic: A Retrospective Observational Study in an Italian University Hospital.

Authors:  Luigi De Maria; Stefania Sponselli; Antonio Caputi; Antonella Pipoli; Gianmarco Giannelli; Giuseppe Delvecchio; Silvia Zagaria; Domenica Cavone; Pasquale Stefanizzi; Francesco Paolo Bianchi; Silvio Tafuri; Luigi Vimercati
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

Review 5.  Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.

Authors:  Chang-Jie Cheng; Chun-Yi Lu; Ya-Hui Chang; Yu Sun; Hai-Jui Chu; Chun-Yu Lee; Chang-Hsiu Liu; Cheng-Huai Lin; Chien-Jung Lu; Chung-Yi Li
Journal:  Vaccines (Basel)       Date:  2021-12-16

Review 6.  COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines.

Authors:  Giuseppina Malcangi; Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Fabio Piras; Vito Settanni; Grazia Garofoli; Giulia Palmieri; Sabino Ceci; Assunta Patano; Antonio Mancini; Luigi Vimercati; Damiano Nemore; Arnaldo Scardapane; Biagio Rapone; Alexandra Semjonova; Maria Teresa D'Oria; Luigi Macchia; Ioana Roxana Bordea; Giovanni Migliore; Antonio Scarano; Felice Lorusso; Gianluca Martino Tartaglia; Delia Giovanniello; Ludovica Nucci; Nicola Maggialetti; Antonio Parisi; Marina Di Domenico; Nicola Brienza; Silvio Tafuri; Pasquale Stefanizzi; Luigi Curatoli; Alberto Corriero; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Children (Basel)       Date:  2022-02-12

7.  Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January-May 2021, Aragon, Spain.

Authors:  Alicia Del Cura-Bilbao; Héctor López-Mendoza; Armando Chaure-Pardos; Alberto Vergara-Ugarriza; Joaquín Guimbao-Bescós
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

8.  BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study.

Authors:  Francesco Paolo Bianchi; Silvio Tafuri; Giovanni Migliore; Luigi Vimercati; Andrea Martinelli; Annamaria Lobifaro; Giusy Diella; Pasquale Stefanizzi
Journal:  Vaccines (Basel)       Date:  2021-10-07

Review 9.  COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021).

Authors:  Sarah M Hatcher; Stacy M Endres-Dighe; Frederick J Angulo; Amit Srivastava; Jennifer L Nguyen; Farid Khan; Catherine Martin; David L Swerdlow; John M McLaughlin; Nneka Ubaka-Blackmore; Linda Morris Brown
Journal:  Vaccines (Basel)       Date:  2022-03-03

10.  Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Cinzia Annatea Germinario; Giovanni Migliore; Luigi Vimercati; Andrea Martinelli; Annamaria Lobifaro; Giusy Diella; Angela Maria Vittoria Larocca; Silvio Tafuri
Journal:  Vaccines (Basel)       Date:  2022-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.